logo-en
  • Home
  • Companies
  • Investors
  • Opportunities
    • Home
    • smLoan.SME_LOANS
  • finTechHub
  • News
LoginRegister
  • english iconenglish
  • english iconarabic
  1. Mubasher News
  2. Apex Pharma’s new pharmaceuticals plant begins operations in Saudi Arabia

Apex Pharma’s new pharmaceuticals plant begins operations in Saudi Arabia

NOHA.GAD
Mar 24, 2025
Apex Pharma launched operations at its first pharmaceuticals plant in Saudi Arabia

Riyadh - Sharikat Mubasher: Apex Pharma, a leading Egyptian pharmaceutical company specializing in high-quality generic medications, launched operations at its first pharmaceutical plant in King Abdullah Economic City (KAEC), according to Chairman Magdy Elba.

The company is expected to begin distributing its products in the Kingdom after the Hajj season, with plans to produce 10 to 14 pharmaceuticals this year, Elba stated in an interview with Alarabiya Business.

He highlighted that the total investment allocated for the project’s first phase is estimated at SAR 300 million, noting that the company has invested SAR 180 million so far.

A few days ago, Apex Pharma launched Mavilor, the first Egyptian medicine for treating high blood pressure manufactured locally in its Saudi plant and approved by the Saudi Food and Drug Authority (SFDA). This milestone underscores the company’s commitment to the highest standards in the advanced pharmaceutical industry.

Elba further revealed that the company plans to invest EGP 3 billion by 2028 to expand its presence in the Egyptian market by adding more production lines and establishing a new pharmaceutical production facility.

In 2018, Apex Pharma signed an agreement with KAEC to establish a pharmaceutical plant in the Kingdom, strengthening the economic partnership between both countries.

The new plant spans a total area of 50,000 square meters and comprises ground and first floors, designed and to be constructed over two phases.

The first phase, covering 13,498 square meters, is dedicated to producing solid dosage forms. It includes commercial batch production areas, a pilot for process developments, a packaging zone, a warehouse, a laboratory area, office spaces, and training rooms.

Meanwhile, the second phase will be built on an area of 9,917 square meters for the complete production of different dosage forms.

Tags

Saudi Arabia
Egypt
Pharmaceuticals
Share

Attract clients with your ad

Start Now

Trending

Saudi real GDP rose by 2.7% in Q1-25
MUBASHER.SA
Saudi Ministry of Investment issues 44 RHQ licenses in Q1-25
MUBASHER.SA
Standard Chartered, Falak Investment launch 3rd Women in Tech Cohort
MUBASHER.SA
Crown Prince unveils HUMAIN, Saudi Arabia’s new AI powerhouse
MUBASHER.SA
Saudi Arabia increases hotel capacity with over 1,000 hotel rooms
MUBASHER.SA

Related News

Investor News
Calendar Icon
May 11, 2025
Tabarak Holding eyes new real estate development project in Kingdom
Read More
Investor News
Calendar Icon
May 11, 2025
CIPS expands presence in Saudi Arabia with new offices
Read More
Investor News
Calendar Icon
May 8, 2025
Stonepeak opens Riyadh office to solidify presence in Middle East
Read More
Investor News
Calendar Icon
May 8, 2025
Career 180 secures six-figure investment to expand into Saudi Arabia
Read More
Investor News
Calendar Icon
May 7, 2025
Capital A accelerates Saudi footprint with multi-sector expansions
Read More
Investor News
Calendar Icon
May 7, 2025
China’s COSCO Shipping establishes subsidiary in Saudi Arabia, opens Dammam office
Read More
Investor News
Calendar Icon
May 6, 2025
Netherlands-based climate innovator CO2Wall expands to Saudi Arabia
Read More

newsLetter.widgetTitle

newsLetter.description

validationMsg.emailRequired
validationMsg.validEmail

footerDesc

  • Home
  • Companies
  • Investors
  • finTechHub
  • Opportunities
  • News
  • ContactUs
  • Sitemap
copyRight